Skip to content

Addiction: all studies

Page 76 of 857: studies 751 to 760 of 8,563, newest first. Back to the addiction overview

Research

Understanding Neuroplasticity Induced by Tryptamines (UNITy): Understanding Neuroplasticity Induced by Tryptamines: Rewiring Maladaptive Memories in Hazardous Drinking with Memory Reactivation and Dimethyltryptamine (DMT)

Open Science Framework October 20, 2025 Natalia Fernandez‐Vinson, Roger Atkins, Marcus J. Glennon et al. preprint

This study examines the existence and mechanistic underpinnings of lasting neural, cognitive, and behavioural plasticity in response to N-N-dimethyltryptamine (DMT) in a hazardous drinking population. It combines behavioural, neuroimaging, ecological momentary and qualitative data to gain a holistic understanding of potential mechanisms of therapeutic change following DMT. Primarily, we test...

Managing Chronic Pain: The Ketamine Option

CNS Drugs October 16, 2025 Gisèle Pickering, Véronique Morel, Marion Voute 2 citations

Ketamine, an anaesthetic and sedative drug, has emerged as a promising therapeutic option for the management of chronic refractory pain, but is used off-label in this indication and known for its psychomimetic side-effects. The primary objective of this manuscript is to synthesize the current evidence on ketamine efficacy and safety for chronic refractory pain. Furthermore, it aims to identify...

Plant-derived hallucinogens: neuropharmacological properties and psychoactive mechanisms — a narrative review

Folia Medica Cracoviensia October 10, 2025 Angelika Ziaja, Ewa Niedzielska, Krzysztof Ciszkowski et al.

INTRODUCTION: Natural hallucinogens have been known since ancient times and were widely used in religious, shamanic, and folk rituals, as well as in traditional medicine. These compounds originate from plants, animals, and fungi and exhibit considerable diversity. Different groups of substances vary in their mechanisms of action, receptor responses, effects induced, and therapeutic...

DOI: 10.24425/fmc.2024.153284 (opens in new tab) Full text (opens in new tab) Addiction Narrative review Hallucinogen Neurotransmitter systems +3

Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms

Journal of Psychoactive Drugs October 10, 2025 Mitch Earleywine, Caitlin Holley, Henry A MacConnel et al.

MDMA-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) shows promise, but attitudes and beliefs about this treatment, especially in symptomatic veterans, remain poorly understood. We sought to explore relevant attitudes in veterans receiving healthcare from Veterans Affairs as a step toward designing relevant surveys or psychoeducation materials for future work. We employed a...

DOI: 10.1080/02791072.2025.2570938 (opens in new tab) Anxiety Psychoeducation Curiosity Narrative +11

The Impact of Yoga and Mindfulness on the Mind and Its Implications for Health and Illness

International Journal of Yoga Sports and Health Sciences September 30, 2025 Nuria Tello Jiménez

In today's times it is necessary to integrate a holistic understanding of the human body, remembering the importance that mind and emotions have in the physical appearance of the body. The purpose of this paper is to provide a comprehensive overview of the benefits of consistent yoga practice and to assess the results of a few chosen articles that investigate the therapeutic effects of yoga....

Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.

Current microbiology July 15, 2025 Gokul Sudhakaran, Shreya Chakraborty, Ashok Kumar et al. 2 citations

Psilocybe species, commonly known as "magic mushrooms", are a group of hallucinogenic fungi known for their psychoactive compounds such as psilocybin, psilocin, baeocystin, and norbaeocystin. These species have been the focus of scientific study due to their potential therapeutic applications, despite their classification as controlled substances in many jurisdictions. This review aims to...

Non-targeted and Targeted Metabolomics Techniques Reveal Striatal Metabolome Characteristics in the Ketamine-Induced Conditioned Place Preference Mice Model.

Journal of Molecular Neuroscience July 12, 2025 Weihao Fan, Yi Ye, Hongkun Yang et al. 1 citation

Ketamine is a synthesized anesthetic drug that was used extensively as a surgical anesthetic in the 1960s. Currently, ketamine is being investigated extensively for its potential as a treatment for depression. However, the addictive nature of ketamine has become an issue that cannot be ignored at this stage. As of now, there is no clear understanding of the changes in striatal metabolites and...

DOI: 10.1007/s12031-025-02382-z (opens in new tab) Full text (opens in new tab) Ketamine addiction ketamine Rewire the brain Neurotransmitters neurotransmitters Kynurenine +9

A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction

Journal of Psychopharmacology July 11, 2025 Diana Glenn, Seung Hee Choi, Rick S. Zimmerman 1 citation

Background: Classic serotonergic psychedelics are 5-HT2A partial agonists that induce non-ordinary states of consciousness. Many have demonstrated anti-addictive properties; however, their impact on smoking behaviors remains under-researched. This review provides a synthesis of the therapeutic potential of these compounds in promoting smoking cessation and reduction. Methods: A systematic...

Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey.

Drug and Alcohol Dependence July 1, 2025 Dilara Bahceci, Krista J. Siefried, Maureen Steele et al.

Methamphetamine use disorder, associated with significant morbidity and mortality, has limited effective treatments. Psychedelic-assisted psychotherapy shows promise, but data on its safety and efficacy in this population are limited. This exploratory study describes the demographic, substance use, and mental health characteristics of people who used methamphetamine and psychedelics and the...

Ketamine-From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks.

Molecules June 30, 2025 Ewa Gibuła-Tarłowska, Anna Wiszniewska, Magdalena Turyk et al. 10 citations

Ketamine, originally developed as an anesthetic, is gaining increasing attention due to its multifaceted pharmacological properties. In addition to its use in anesthesia, ketamine exerts potent analgesic effects via N-methyl-D-aspartate (NMDA) receptor antagonism, modulating pain perception and reducing central sensitization, particularly in chronic and neuropathic pain conditions. Emerging...